Pharmacologic adjuncts to mechanical ventilation in acute respiratory distress syndrome

Critical Care Clinics

Volumn 14, Issue 4, 1998, Pages 581-610

  Albertson, T E ^a   Marelich, G P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; ACETYLCYSTEINE; ALMITRINE; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; BRONCHODILATING AGENT; CORTICOSTEROID; KETANSERIN; KETOCONAZOLE; PENTOXIFYLLINE; SELENIUM; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG RESEARCH; HUMAN; IMMUNOTHERAPY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031665986     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70022-1     Document Type: Article

References (232)

1. I.Y. Adamson L. Young J. Bakowska Enhanced alveolar type II cell growth on a pulmonary extracellular matrix over fibroblasts Am J Physiol 272 1997 L413
2. C.M. Ahn H. Sandler M. Glass Effect of a synthetic leukocyte elastase inhibitor on thrombin-induced pulmonary edema in the rat Exp Lung Res 19 1993 125
3. B. Amy P. LeGrand M. Levitzky Suppression of centrineurogenic shock lung by Dilantin (DPH) administered early in established hemorrhagic shock J Trauma 21 1981 762
4. C.P. Andrews J.J. Coalson J.D. Smith Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury Chest 80 1981 254
5. A. Anzueto R.P. Baughman K.K. Guntupalli Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group N Engl J Med 334 1996 1417
6. A. Anzueto A. Jubran J.A. Ohar Effects of aerosolized surfactant in patients with stable chronic bronchitis: A prospective randomized controlled trial JAMA 278 1997 1426
7. D.G. Ashbaugh D.B. Bigelow T.L. Petty Acute respiratory distress in adults Lancet 2 1967 319
8. D.G. Ashbaugh R.V. Maier Idiopathic pulmonary fibrosis in adult respiratory distress syndrome. Diagnosis and treatment Arch Surg 120 1985 530
9. M.E. Avery T.A. Merritt Surfactant-replacement therapy N Engl J Med 324 1991 910
10. A. Bacher N. Mayer W. Klimscha Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients Crit Care Med 25 1997 795
11. P.A. Bardsley P. Howard W. DeBacker Two years treatment with almitrine bismesylate in patients with hypoxic chronic obstructive airways disease Eur Resp J 4 1991 308
12. M.L. Barnard W.G. Olivera D.M. Rutschman Dopamine stimulates sodium transport and liquid clearance in rat lung epithelium Am J Respir Crit Care Med 156 1997 709
13. G.S. Basran J.G. Hardy S.P. Woo Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabeled transferrin in the adult respiratory distress syndrome in man Eur J Nucl Med 12 1986 381
14. J. Behr K. Maier B. Degenkolb Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression Am J Respir Crit Care Med 156 1997 1897
15. G.R. Bernard J.M. Luce C.L. Sprung High-dose corticosteroids in patients with the adult respiratory distress syndrome N Engl J Med 317 1987 1565
16. G.R. Bernard A.P. Wheeler M.M. Arons A trial of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Study Group Chest 112 1997 164
17. G.R. Bernard A.P. Wheeler J.A. Russell The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group N Engl J Med 336 1997 912
18. T.S. Blackwell T.R. Blackwell J.W. Christman Impaired activation of nuclear factor-kappa B in endotoxin-tolerant rats is associated with down-regulation of chemokine gene expression and inhibition of neutrophilic lung inflammation J Immunol 158 1997 5934
19. T.S. Blackwell T.R. Blackwell E.P. Holden In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation J Immunol 157 1996 1630
20. B.T. Bloom J. Kattwinkel R.T. Hall Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome Pediatrics 100 1997 31
21. R.C. Bone The pathogenesis of sepsis Ann Intern Med 115 1991 457
22. R.C. Bone C.J. Fisher Jr T.P. Clemmer Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome [published erratum appears in Chest 1988 Aug;94(2):448] Chest 92 1987 1032
23. T. Borg B. Gerdin J. Modig Prophylactic and delayed treatment with indomethacin in a porcine model of early adult respiratory distress syndrome induced by endotoxaemia Acta Anaesthesiol Scand 30 1986 47
24. S. Braude P. Haslam D. Hughes Chronic adult respiratory distress syndrome—a role for corticosteroids? Crit Care Med 20 1992 1187
25. K.L. Brigham Role of free radicals in lung injury Chest 89 1986 859
26. C.L. Bryan R.E. Lewis S.L. Owens Allopurinol inhibition of neutrophilic alveolar response during hyperoxia J Appl Physiol 75 1993 357
27. S. Bursten R. Weeks J. West Potential role for phosphatidic acid in mediating the inflammatory responses to TNF alpha and IL-1 beta Circ Shock 44 1994 14
28. S.L. Bursten D.A. Federighi P. Parsons An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome Crit Care Med 24 1996 1129
29. K. Byrne T.D. Sielaff B. Michna Increased survival time after delayed histamine and prostaglandin blockade in a porcine model of severe sepsis-induced lung injury Crit Care Med 18 1990 303
30. T. Calandra M.P. Glauser J. Schellekens Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: A prospective, double-blind, randomized trial J Infect Dis 158 1988 312
31. E.P. Carter O.D. Wangensteen S.M. O'Grady Effects of hyperoxia on type II cell Na-K-ATPase function and expression Am J Physiol 272 1997 L542
32. A.N. Chesnutt F. Kheradmand H.G. Folkesson Soluble transforming growth factor-alpha is present in the pulmonary edema fluid of patients with acute lung injury Chest 111 1997 652
33. S. Chollet-Martin C. Gatecel N. Kermarrec Alveolar neutrophil functions and cytokine levels in patients with the adult respiratory distress syndrome during nitric oxide inhalation Am J Respir Crit Care Med 153 1996 985
34. P. Christner A. Fein S. Goldberg Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome Am Rev Respir Dis 131 1985 690
35. J.G. Clark J.A. Milberg K.P. Steinberg Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death Ann Intern Med 122 1995 17
36. S.M. Cohn K.L. Kruithoff H.R. Rothschild Beneficial effects of LY203647, a novel leukotriene C4/D4 antagonist, on pulmonary function and mesenteric perfusion in a porcine model of endotoxic shock and ARDS Circ Shock 33 1991 7
37. H. Cottier C. Ruchti A. Burkhardt Adult Respiratory Distress Syndrome due to an acute breach in the intestinal barrier: Should high-dose intravenous immunoglobulin therapy be tested? Vox Sang 58 1990 311
38. C.E. Cross T. Forte R. Stocker Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome J Lab Clin Med 115 1990 396
39. J.J. Cummings B.A. Holm M.L. Hudak A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs Am Rev Respir Dis 145 1992 999
40. E.A. Davies A.J.D. Campbell M.J. Devine Ibuprofen plus prostaglandin E1 in a septic porcine model of adult respiratory distress syndrome J Trauma 29 1989 284
41. J.M. Davis W.N. Rosenfeld S.E. Richter Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome Pediatrics 100 1997 24
42. G. Deby-Dupont M. Braun M. Lamy Thromboxane and prostacyclin release in adult respiratory distress syndrome Intensive Care Med 13 1987 167
43. W. Druml H. Steltzer W. Waldhäusl Endothelin-1 in adult respiratory distress syndrome Am Rev Respir Dis 148 1993 1169
44. G. Enhorning Surfactant replacement in adult respiratory distress syndrome Am Rev Respir Dis 140 1989 281
45. D.A. Evans D.O. Jacobs A. Revhaug The effects of tumor necrosis factor and their selective inhibition by ibuprofen Ann Surg 209 1989 312
46. D.A. Evans R.W. Wilmott J.A. Whitsett Surfactant replacement therapy for adult respiratory distress syndrome in children Pediatr Pulmonol 21 1996 328
47. Executive Summary of an American College of Chest Physicians NIoAaID, and National Heart, Lung, and Blood Institute Workshop From the bench to the bedside: The future of sepsis research Chest 111 1997 744
48. I.S. Farrukh J.R. Michael S.P. Peters The role of cyclooxygenase and lipoxygenase mediators in oxidant-induced lung injury Am Rev Respir Dis 137 1988 1343
49. A. Fein R.F. Grossman J.G. Jones The value of edema fluid protein measurement in patients with pulmonary edema Am J Med 67 1979 32
50. M.P. Fink B.P. O'Sullivan M.J. Menconi A novel leukotriene B4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model Crit Care Med 21 1993 1825
51. M.R. Flick J.F. Murray High-dose corticosteroid therapy in the adult respiratory distress syndrome JAMA 251 1984 1054
52. M.R. Flick R.O. Webster J.M. Hoeffel Effect of phenytoin on acute lung injuries in unanesthetized sheep Crit Care Med 21 1993 1563
53. A.A. Fowler T.M. Hyers B.J. Fisher The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk Am Rev Respir Dis 136 1987 1225
54. L.A. Frazee J.A. Neidig Ketoconazole to prevent acute respiratory distress syndrome in critically ill patients Ann Pharmacother 29 1995 784
55. E.A. Frey D.S. Miller T.G. Jahr Soluble CD14 participates in the response of cells to lipopolysaccharide J Exp Med 176 1992 1665
56. A.B. Froese Exogenous surfactant therapy in ARDS. Lessons from the neonatal ICU Chest 105 1994 1310
57. J.E. Gadek E.R. Pacht The interdependence of lung antioxidants and antiprotease defense in ARDS Chest 110 1996 273S
58. H.F. Galley P.D. Howdle B.E. Walker The effects of intravenous antioxidants in patients with septic shock Free Radic Biol Med 23 1997 768
59. S. Gando T. Kameue S. Nanzaki Increased neutrophil elastase, persistent intravascular coagulation, and decreased fibrinolytic activity in patients with posttraumatic acute respiratory distress syndrome J Trauma 42 1997 1068
60. B.J. Gentile M.J. Durkot B.A. Krestel Effects of almitrine bismesylate in a microswine model of hypoxemic hypothermia Aviat Space Environ Med 68 1997 824
61. D. Georgopoulos I. Mitrouska P. Argyropoulou Effect of hypoxic sensitivity on decay of respiratory short-term potentiation Chest 107 1995 150
62. J.D. Gitlin R.F. Soll R.B. Parad Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease Pediatrics 79 1987 31
63. W. Glinz P.J. Grob U.E. Nydegger Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study Intensive Care Med 11 1985 288
64. D. Gommers A. Hartog A. van't Veen Improved oxygenation by nitric oxide is enhanced by prior lung reaeration with surfactant, rather than positive end-expiratory pressure, in lung-lavaged rabbits Crit Care Med 25 1997 1868
65. P.K. Gonzalez J. Zhuang S.R. Doctrow EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine J Pharmacol Exp Ther 275 1995 798
66. P.K. Gonzalez J. Zhuang S.R. Doctrow Role of oxidant stress in the adult respiratory distress syndrome: Evaluation of a novel antioxidant strategy in a porcine model of endotoxin-induced acute lung injury Shock 1 6 Suppl 1996 S23
67. T.J. Gregory W.J. Longmore M.A. Moxley Surfactant repletion following Survanta supplementation in patients with acute respiratory distress syndrome (ARDS) Am J Respir Crit Care Med 149 1994 A124
68. T.J. Gregory J.E. Gadek J.E. Weiland Survanta supplementation in patients with acute respiratory distress syndrome (ARDS) Am J Respir Crit Care Med 149 1994 A567
69. T.J. Gregory K.P. Steinberg R. Spragg Bovine surfactant therapy for patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 1997 1309
70. B.P. Guery C.M. Mason E.P. Dobard Keratinocyte growth factor increases transalveolar sodium reabsorption in normal and injured rat lungs Am J Respir Crit Care Med 155 1997 1777
71. D.M. Guidot G.C. Rice J.W. Singer Inhibition of lyso-phosphatidic acid acyl transferase (LPSST) activity by CT1501R suppresses neutrophil adherence and chemotaxis in vitro and decreases interleukin-8 (IL-8)-induced injury in isolated rat lungs perfused with human neutrophils Clin Res 42 1994 145A
72. N. Guinard S. Beloucif C. Gatecel Interest of a therapeutic optimization strategy in severe ARDS Chest 111 1997 1000
73. A. Günther C. Siebert R. Schmidt Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema Am J Respir Crit Care Med 153 1996 176
74. J.M. Gutteridge G.J. Quinlan S. Mumby Primary plasma antioxidants in adult respiratory distress syndrome patients: Changes in iron-oxidizing, iron-binding, and free radical-scavenging proteins J Lab Clin Med 124 1994 263
75. E. Hailman H.S. Lichenstein M.M. Wurfel Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 J Exp Med 179 1994 269
76. H.L. Halliday Overview of clinical trials comparing natural and synthetic surfactants Biol Neonate 1 1995 32
77. M. Hallman P. Maasilta I. Sipilä Composition and function of pulmonary surfactant in adult respiratory distress syndrome Eur Respir J Suppl 3 1989 104S
78. F. Hammarqvist J.L. Luo I.A. Cotgreave Skeletal muscle glutathione is depleted in critically ill patients Crit Care Med 25 1997 78
79. R.M. Hardaway H. Harke C.H. Williams Fibrinolytic agents: A new approach to the treatment of adult respiratory distress syndrome Adv Ther 11 1994 43
80. R.M. Hardaway C.H. Williams M. Marvasti Prevention of adult respiratory distress syndrome with plasminogen activator in pigs Crit Care Med 18 1990 1413
81. N. Hasegawa Y. Oka M. Nakayama The effect of inhibition of phosphatidic acid generation by lisofylline on sepsis-induced acute lung injury in minipigs Am J Respir Crit Care Med 151 1995 A764
82. P.L. Haslam D.A. Hughes P.D. MacNaughton Surfactant replacement therapy in late-stage adult respiratory distress syndrome Lancet 343 1994 1009
83. M.T. Haupt M.S. Jastremski T.P. Clemmer Effect of ibuprofen in patients with severe sepsis: A randomized, double-blind, multicenter study. The Ibuprofen Study Group Crit Care Med 19 1991 1339
84. J.E. Heffner J.E. Repine Pulmonary strategies of antioxidant defense Am Rev Respir Dis 140 1989 531
85. H. Hoffmann J.R. Hatherill J. Crowley Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs Am Rev Respir Dis 143 1991 289
86. B.A. Holm R.H. Notter Surfactant replacement therapy D.L. Shapiro R.H. Notter Surfactant Replacement Therapy 1989 Alan R Liss New York 273
87. R.G. Hooper ARDS: Inflammation, infections, and corticosteroids Chest 100 1991 889
88. R.G. Hooper R.A. Kearl Established ARDS treated with a sustained course of adrenocortical steroids Chest 97 1990 138
89. J.D. Horbar R.F. Soll J.M. Sutherland A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome N Engl J Med 320 1989 959
90. R.E. Howell L.P. Jenkins D.E. Howell Inhibition of lipopolysaccharide-induced pulmonary edema by isozyme-selective phosphodiesterase inhibitors in guinea pigs J Pharmacol Exp Ther 275 1995 703
91. S.L. Huang C.H. Su S.C. Chang Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis Am J Respir Crit Care Med 156 1997 1436
92. M.L. Hudak D.J. Martin E.A. Egan A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome Pediatrics 100 1997 39
93. W.V. Huval S. Lelcuk D. Shepro Role of serotonin in patients with acute respiratory failure Ann Surg 200 1984 166
94. S.G. Jenkinson R.J. Roberts R.A. DeLemos Allopurinol-induced effects in premature baboons with respiratory distress syndrome J Appl Physiol 70 1991 1160
95. S. Jepsen P. Herlevsen P. Knudsen Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo-controlled study Crit Care Med 20 1992 918
96. A.H. Jobe Pulmonary surfactant therapy N Engl J Med 328 1993 861
97. P. Jolliet P. Bulpa M. Ritz Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in acute respiratory distress syndrome Crit Care Med 25 1997 786
98. J.W. Kendig R.H. Notter C. Cox A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation N Engl J Med 324 1991 865
99. H.J. Kim C.A. Henke S.K. Savik Integrin mediation of alveolar epithelial cell migration on fibronectin and type I collagen Am J Physiol 273 1997 L134
100. L.D. Klima M.K. Greer T.R. Martin Transforming growth factor-alpha (TGF-alpha) in alveolar epithelial cell repair: Clinical and experimental evidence Am J Respir Crit Care Med 151 1995 A78
101. M.H. Kollef D.P. Schuster The acute respiratory distress syndrome N Engl J Med 332 1995 27
102. P. Krafft P. Fridrich T. Pernerstorfer The acute respiratory distress syndrome: Definitions, severity and clinical outcome. An analysis of 101 clinical investigations Intensive Care Med 22 1996 519
103. A. Kullman P. Vaillant V. Muller In vitro effects of pentoxifylline on smooth muscle cell migration and blood monocyte production of chemotactic activity for smooth muscle cells: Potential therapeutic benefit in the adult respiratory distress syndrome Am J Respir Cell Mol Biol 8 1993 83
104. B. Lachmann Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome Eur Respir J Suppl 3 1989 98S
105. B. Lachmann The role of pulmonary surfactant in the pathogenesis and therapy of ARDS J.L. Vincent Update in Intensive Care and Emergency Medicine 1987 Springer Berlin 123
106. B. Lachmann Surfactant therapy Resuscitation 18 1989 S37
107. D. Langleben M. DeMarchie D. Laporta Endothelin-1 in acute lung injury and the adult respiratory distress syndrome Am Rev Respir Dis 148 1993 1646
108. J.M. Lasnier O.D. Wangensteen L.S. Schmitz Terbutaline stimulates alveolar fluid resorption in hyperoxic lung injury J Appl Physiol 81 1996 1723
109. T. Laurent M. Markert F. Feihl Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine Chest 109 1996 163
110. M. Leeman J.M. Boeynaems J.P. Degaute Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome Chest 87 1985 726
111. J.A. Leff P.E. Parsons C.E. Day Serum antioxidants as predictors of adult respiratory distress syndrome in patients with sepsis Lancet 341 1993 777
112. D.J. Leturcq A.M. Moriarty G. Talbott Antibodies against CD14 protect primates from endotoxin-induced shock J Clin Invest 98 1996 1533
113. J. Lewis J. Dhillon T. Frewen Exogenous surfactant therapy in pediatric patients with ARDS Am J Respir Crit Care Med 149 1994 A125
114. J.F. Lewis A.H. Jobe Surfactant and the adult respiratory distress syndrome [published erratum appears in Am Rev Respir Dis 1993 Apr;147(4):following 1068] Am Rev Respir Dis 147 1993 218
115. X.Y. Li K. Donaldson D. Brown The role of tumor necrosis factor in increased airspace epithelial permeability in acute lung inflammation Am J Respir Cell Mol Biol 13 1995 185
116. S. Louie B. Halliwell C.E. Cross Adult respiratory distress syndrome: A radical perspective Adv Pharmacol 38 1997 457
117. Q. Lu E. Mourgeon J.D. Law-Koune Dose-response curves of inhaled nitric oxide with and without intravenous almitrine in nitric oxide-responding patients with acute respiratory distress syndrome Anesthesiology 83 1995 929
118. J.M. Luce A.B. Montgomery J.D. Marks Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock Am Rev Respir Dis 138 1988 62
119. P.D. Macnaughton T.W. Evans The effect of exogenous surfactant therapy on lung function following cardiopulmonary bypass Chest 105 1994 421
120. W.M. Maniscalco R.H. Watkins C.T. D'Angio Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung Am J Respir Cell Mol Biol 16 1997 557
121. M. Marcoli G. Ricevuti F. Fasani Assessment of lymphocyte and phagocytic cell function in healthy volunteers undergoing short-term phenytoin administration Int J Immunopharmacol 9 1987 903
122. G.D. Martich M.M. Parker R.E. Cunnion Effects of ibuprofen and pentoxifylline on the cardiovascular response of normal humans to endotoxin J Appl Physiol 73 1992 925
123. T.R. Martin J.C. Mathison P.S. Tobias Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide. Implications for cytokine production in normal and injured lungs J Clin Invest 90 1992 2209
124. T.R. Martin G.D. Rubenfeld J.T. Ruzinski Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 1997 937
125. R.J. Maunder W.P. Shuman J.W. McHugh Preservation of normal lung regions in the adult respiratory distress syndrome. Analysis by computed tomography JAMA 255 1986 2463
126. G.U. Meduri Late adult respiratory distress syndrome New Horizons 1 1993 563
127. G.U. Meduri J.M. Belenchia R.J. Estes Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids Chest 100 1991 943
128. G.U. Meduri A.J. Chinn K.V. Leeper Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome Chest 105 1994 1516
129. G.U. Meduri S. Headley E. Tolley Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS Chest 108 1995 1315
130. G.U. Meduri G. Kohler S. Headley Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome Chest 108 1995 1303
131. G.U. Meduri K.V. Leeper E. Tolley Inflammatory cytokines response to high-dose corticosteroids in late ARDS Chest 104 1993 12S
132. J. Millili Improved clinical outcome in adult respiratory distress syndrome (ARDS) treated with antioxidants Free Radic Biol Med 15 1993 512
133. M. Miniati F. Cocci S. Monti Lazaroid U-74389F attenuates phorbol ester-induced lung injury in rabbits Eur Respir J 9 1996 758
134. P. Moine R. Shenkar D. Kaneko Systemic blood loss affects NF-kappa B regulatory mechanisms in the lungs Am J Physiol 273 1997 L185
135. P. Montravers J.Y. Fagon C. Gilbert Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome Chest 103 1993 1017
136. M. Moss L. Ackerson M.K. Gillespie Von Willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome Am J Respir Crit Care Med 151 1995 15
137. J.D. Mrozek K.M. Smith D.R. Bing Exogenous surfactant and partial liquid ventilation: Physiologic and pathologic effects Am J Respir Crit Care Med 156 1997 1058
138. A.B. Nathens R. Bitar C. Davreux Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury Am J Respir Cell Mol Biol 17 1997 608
139. G.F. Nieman L.A. Gatto A.M. Paskanik Surfactant replacement in the treatment of sepsis-induced adult respiratory distress syndrome in pigs Crit Care Med 24 1996 1025
140. S. Nosaka T. Sakai M. Yonekura Surfactant for adults with respiratory failure Lancet 336 1990 947
141. J.T. Owings M. Bagley R. Gosselin Effect of critical injury on plasma antithrombin activity: Low antithrombin levels are associated with thromboembolic complications J Trauma 41 1996 396
142. E.R. Pacht A.P. Timerman M.G. Lykens Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome Chest 100 1991 1397
143. J.E. Parrillo Pathogenetic mechanisms of septic shock N Engl J Med 328 1993 1471
144. P.E. Parsons G.S. Worthen E.E. Moore The association of circulating endotoxin with the development of the adult respiratory distress syndrome Am Rev Respir Dis 140 1989 294
145. A. Pesenti P. Pelosi N. Rossi Respiratory mechanics and bronchodilator responsiveness in patients with the adult respiratory distress syndrome Crit Care Med 21 1993 78
146. U. Pison W. Seeger R. Buchhorn Surfactant abnormalities in patients with respiratory failure after multiple trauma Am Rev Respir Dis 140 1989 1033
147. J.F. Prost P. Desché F. Jardin Comparison of the effects of intravenous almitrine and positive end-expiratory pressure on pulmonary gas exchange in adult respiratory distress syndrome Eur Respir J 4 1991 683
148. J. Pugin C.C. Schürer-Maly D. Leturcq Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14 Proc Natl Acad Sci USA 90 1993 2744
149. G. Putz C. Hörmann W. Koller Surfactant replacement therapy in acute respiratory distress syndrome from viral pneumonia Intensive Care Med 22 1996 588
150. G.J. Quinlan T.W. Evans J.M.C. Gutteridge Measurement of metatyrosine, ortho-tyrosine and kynurene in BAL proteins of patients with ARDS: Evidence for the formation of hydroxyl radicals Thorax 50 1995 A69
151. G.J. Quinlan N.J. Lamb T.W. Evans Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome Crit Care Med 24 1996 241
152. G.J. Quinlan N.J. Lamb R. Tilley Plasma hypoxanthine levels in ARDS: Implications for oxidative stress, morbidity, and mortality Am J Respir Crit Care Med 155 1997 479
153. P. Radermacher Y. Huet F. Pluskwa Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS Anesthesiology 68 1988 152
154. T.B. Redens W.J. Leach D.A. Bogdanoff Synergistic protection from lung damage by combining antithrombin-III and alpha 1-proteinase inhibitor in the E. coli endotoxemic sheep pulmonary dysfunction model Circ Shock 26 1988 15
155. H.D. Reines P.V. Halushka L.S. Olanoff Dazoxiben in human sepsis and adult respiratory distress syndrome Clin Pharmacol Ther 37 1985 391
156. I. Reiss M. Kohl T.F. Schaible Treatment of children with ARDS transferred for ECMO with surfactant and nitric oxide - a pilot study in 23 patients Crit Care Med 26 1998 A119
157. H. Renz J.H. Gong A. Schmidt Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides J Immunol 141 1988 2388
158. A. Reyes J.B. López-Messa P. Alonso Almitrine in acute respiratory failure. Effects on pulmonary gas exchange and circulation Chest 91 1987 388
159. C. Richard F. Lemonnier M. Thibault Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome Crit Care Med 18 1990 4
160. P.S. Richman R.G. Spragg T.A. Merritt Administration of porcine-lung surfactant to humans with ARDS: Initial experience Am Rev Respir Dis 135 1987 A5
161. P.S. Richman R.G. Spragg B. Robertson The adult respiratory distress syndrome: First trials with surfactant replacement Eur Respir J Suppl 3 1989 109S
162. J.E. Rinaldo B. Pennock Effects of ibuprofen on endotoxin-induced alveolitis: Biphasic dose response and dissociation between inflammation and hypoxemia Am J Med Sci 291 1986 29
163. W.N. Rosenfeld J.M. Davis L. Parton Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome Pediatrics 97 1996 811
164. D.B. Rubin J.P. Wiener-Kronish J.F. Murray Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome J Clin Invest 86 1990 474
165. S.I. Said H.D. Foda Pharmacologic modulation of lung injury Am Rev Respir Dis 139 1989 1553
166. T. Sakuma H.G. Folkesson S. Suzuki Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs Am J Respir Crit Care Med 155 1997 506
167. T. Sakuma G. Okaniwa T. Nakada Alveolar fluid clearance in the resected human lung Am J Respir Crit Care Med 150 1994 305
168. K. Saldeen R.G. Andersson Effect of a peptide derived from fibrinogen degraded by leukocyte elastase on isolated bovine mesenteric arteries Thromb Res 53 1989 279
169. M.A.J. Sawyer J.J. Mike K. Chavin Antioxidant therapy and survival in ARDS Crit Care Med 17 1989 5153
170. H. Schmidt W. Schmidt T. Müller N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo Crit Care Med 25 1997 858
171. M.D. Schwartz E.E. Moore F.A. Moore Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome Crit Care Med 24 1996 1285
172. R.M. Schwartz A.M. Luby J.W. Scanlon Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g N Engl J Med 330 1994 1476
173. B.C. Sheridan R.C. McIntyre D.R. Meldrum Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury J Surg Res 71 1997 150
174. J.Y. Shih S.C. Yang Y.C.J. Yu Elevated serum levels of mucin-associated antigen in patients with acute respiratory distress syndrome Am J Respir Crit Care Med 156 1997 1453
175. W.J. Sibbald R.R. Anderson B. Reid Alveolo-capillary permeability in human septic ARDS. Effect of high-dose corticosteroid therapy Chest 79 1981 133
176. U. Siebenlist G. Franzoso K. Brown Structure, regulation and function of NF-kappa B Ann Rev Cell Biol 10 1994 405
177. T.D. Sielaff H.J. Sugerman J.L. Tatum Successful treatment of adult respiratory distress syndrome by histamine and prostaglandin blockade in a porcine Pseudomonas model Surgery 102 1987 350
178. T.D. Sielaff H.J. Sugerman J.L. Tatum Treatment of porcine Pseudomonas ARDS with combination drug therapy J Trauma 27 1987 1313
179. T.M. Siler J.E. Swierkosz T.M. Hyers Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome Exp Lung Res 15 1989 881
180. G.J. Slotman K.W. Burchard A. D'Arezzo Ketoconazole prevents acute respiratory failure in critically ill surgical patients J Trauma 28 1988 648
181. L.S. Snyder M.I. Hertz M.S. Peterson Acute lung injury. Pathogenesis of intraalveolar fibrosis J Clin Invest 88 1991 663
182. R.G. Spragg N. Gilliard P. Richman Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome Chest 105 1994 195
183. C.L. Sprung P.V. Caralis E.H. Marcial The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study N Engl J Med 311 1984 1137
184. K.P. Steinberg J.A. Milberg T.R. Martin Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome Am J Respir Crit Care Med 150 1994 113
185. S. Steinberg D. Dehring D. Martin Amelioration of pulmonary pathophysiology of adult respiratory distress syndrome by sulindac, a cyclo-oxygenase inhibitor J Trauma 27 1987 1323
186. F. Stüber M. Petersen F. Bokelmann A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis Crit Care Med 24 1996 381
187. Z.E. Suntres P.N. Shek Treatment of LPS-induced tissue injury: Role of liposomal antioxidants Shock 1 6 Suppl 1996 S57
188. P. Suter Therapeutic approach in early and late ARDS Acta Anaesthesiol Scand Suppl 110 1997 48
189. P.M. Suter G. Domenighetti M.D. Schaller N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study Chest 105 1994 190
190. P.M. Suter S. Suter E. Girardin High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis Am Rev Respir Dis 145 1992 1016
191. Y. Suzuki T. Tanigaki D. Heimer Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs Am Rev Respir Dis 145 1992 388
192. Y. Takao K. Mikawa K. Nishina Lidocaine attenuates hyperoxic lung injury in rabbits Acta Anaesthesiol Scand 40 1996 318
193. W.O. Tarnow-Mordi R.F. Soll Artificial versus natural surfactant—can we base clinical practice on a firm scientific footing? Eur J Pediatr 153 1994 S17
194. J.B. Thorens P. Jolliet J.C. Chevrolet Prolonged treatment with almitrine for refractory hypoxemia in adult respiratory distress syndrome Chest 105 1994 1579
195. F.A. Tibayan A.N. Chesnutt H.G. Folkesson Dobutamine increases alveolar liquid clearance in ventilated rats by beta-2 receptor stimulation Am J Respir Crit Care Med 156 1997 438
196. P.S. Tobias K. Soldau R.J. Ulevitch Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum J Exp Med 164 1986 777
197. J.M. Travaline S. Sudarshan B.G. Roy Effect of N-acetylcysteine on human diaphragm strength and fatigability Am J Respir Crit Care Med 156 1997 1567
198. C.R. Turner K.M. Esser E.B. Wheeldon Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition Circ Shock 39 1993 237
199. C.R. Turner M.N. Lackey M.F. Quinlan Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibition Circ Shock 34 1991 263
200. C.R. Turner M.F. Quinlan L.W. Schwartz Therapeutic intervention in a rat model of ARDS: I. Dual inhibition of arachidonic acid metabolism Circ Shock 32 1990 231
201. M. Uchiba K. Okajima K. Murakami Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats Am J Hematol 54 1997 118
202. M. Uchiba K. Okajima K. Murakami Recombinant human soluble thrombomodulin reduces endotoxin-induced pulmonary vascular injury via protein C activation in rats Thromb Haemost 74 1995 1265
203. T. Utsunomiya M.M. Krausz C.R. Valeri Treatment of aspiration pneumonia with ibuprofen and prostacyclin Surgery 90 1981 170
204. VA Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group N Engl J Med 317 1987 659
205. A.M. van Furth E.M. Verhard-Seijmonsbergen R. van Furth Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta, IL-10 by human leucocytes Immunology 91 1997 193
206. J.M. Van Neuten P.A. Janssen J. Van Beek Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors J Pharmacol Exp Ther 218 1981 217
207. E. Vannier L.C. Miller C.A. Dinarello Histamine suppresses gene expression and synthesis of tumor necrosis factor alpha via histamine H2 receptors J Exp Med 174 1991 281
208. K.A. Veness-Meehan B.M. Moats-Staats W.A. Price Re-emergence of a fetal pattern of insulin-like growth factor expression during hyperoxic rat lung injury Am J Respir Cell Mol Biol 16 1997 538
209. J.L. Vincent J.P. Degaute M. Domb Ketanserin, a serotonin antagonist. Administration in patients with acute respiratory failure Chest 85 1984 510
210. D. Walmrath A. Günther H.A. Ghofrani Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis Am J Respir Crit Care Med 154 1996 57
211. W. Wang P. Wang I.H. Chaudry Pentoxifylline increases gut ketogenesis following trauma and hemorrhagic shock Crit Care Med 26 1998 101
212. C.M. Waters U. Savla R.J. Panos KGF prevents hydrogen peroxide-induced increases in airway epithelial cell permeability Am J Physiol 272 1997 L681
213. K. Waxman K. Daughters S. Aswani Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock Crit Care Med 24 1996 1724
214. J.G. Weg R.A. Balk R.S. Tharratt Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome JAMA 272 1994 1433
215. H. Weidmann R. Baughman B. deBoisblanc A multicenter trial in human sepsis-iduced ARDS of an aerosolized synthetic surfactant (Exosurf) Am Rev Respir Dis 145 1992 A184
216. J.A. Weigelt J.F. Norcross K.R. Borman Early steroid therapy for respiratory failure Arch Surg 120 1985 536
217. J.E. Weiland W.B. Davis J.F. Holter Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance Am Rev Respir Dis 133 1986 218
218. A. Wilkinson P.A. Jenkins J.A. Jeffrey Two controlled trials of dry artificial surfactant: Early effects and later outcome in babies with surfactant deficiency Lancet 2 1985 287
219. J.G. Williams R.V. Maier Ketoconazole inhibits alveolar macrophage production of inflammatory mediators involved in acute lung injury (adult respiratory distress syndrome) Surgery 112 1992 270
220. D.F. Willson J.H. Jiao L.A. Bauman Calf's lung surfactant extract in acute hypoxemic respiratory failure in children Crit Care Med 24 1996 1316
221. A.G. Wilson F.S. di Giovine A.I. Blakemore Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product Hum Mol Genet 1 1992 353
222. B.R. Winkelmann T.H. Kullmer D.G. Kneissl Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease Chest 105 1994 1383
223. D. Wisner J. Sturm G. Sutter Thromboxane receptor blockade in an animal model of ARDS Surgery 104 1988 91
224. H.R. Wolf H.W. Seeger Experimental and clinical results in shock lung treatment with vitamin E Ann NY Acad Sci 393 1982 392
225. C.H. Wortel C.M. Doerschuk Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome New Horizons 1 1993 631
226. P.E. Wright G.R. Bernard The role of airflow resistance in patients with the adult respiratory distress syndrome Am Rev Respir Dis 139 1989 1169
227. P.E. Wright L.C. Carmichael G.R. Bernard Effect of bronchodilators on lung mechanics in the acute respiratory distress syndrome (ARDS) Chest 106 1994 1517
228. S.D. Wright R.A. Ramos P.S. Tobias CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 1990 1431
229. M. Yu G. Tomasa A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome Crit Care Med 21 1993 1635
230. F. Zeni B. Freeman C. Natanson Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment Crit Care Med 25 1997 1095
231. Y. Zhao B.J. Gilmore S.L. Young Expression of transforming growth factor-beta receptors during hyperoxia-induced lung injury and repair Am J Physiol 273 1997 L355
232. E.J. Ziegler J.A. McCutchan J. Fierer Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli N Engl J Med 307 1982 1225